Catalyst Pharmaceuticals Inc
NASDAQ:CPRX

Watchlist Manager
Catalyst Pharmaceuticals Inc Logo
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Watchlist
Price: 22.86 USD 6.82%
Market Cap: 2.8B USD

P/E
Price to Earnings

16.9
Current
19.4
Median
22.3
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
16.9
=
Market Cap
2.5B USD
/
Net Income
163.9m USD
Earnings Growth PEG
US
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Average P/E: 67.6
16.9
10%
1.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -171 782.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
73.8
87%
0.8
US
Amgen Inc
NASDAQ:AMGN
38
44%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
268.6
187%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -231.2 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -497.4 N/A N/A
AU
CSL Ltd
ASX:CSL
24.5
16%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.1
12%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.6 N/A N/A
NL
argenx SE
XBRU:ARGX
37.4
26%
1.4

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
14.3
2-Years Forward
P/E
12.3
3-Years Forward
P/E
11.5